II.7 The progestin-like activity of tamoxifen on the endometrium

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Dallenbach Hellweg, G ^a   Schmidt, D ^a  

^a Institute für Pathologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GESTAGEN; TAMOXIFEN;

ADULT; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CLEAR CELL CARCINOMA; CONFERENCE PAPER; DRUG ACTIVITY; DRUG CONTRAINDICATION; ENDOMETRIUM BIOPSY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METAPLASIA; MIXED TUMOR; PRIORITY JOURNAL;

EID: 0031715130     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00096-3     Document Type: Conference Paper

References (10)

1. Assikis VJ, Neven P, Jordan VC, et al. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 1996, 32A, 1464-1476.
2. Nuovo MA, Nuovo GJ, McCaffrey RM, Levine RU, Winkler B. Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 1989, 8, 125-131.
3. Segna RA, Dottino PR, Deligdisch L, Cohen CJ. Tamoxifen and endometrial cancer. Mt Sinai J Med 1992, 59, 416-418.
4. Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994, 47, 827-833.
5. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993, 11, 485-490.
6. Corley D, Rowe J, Curtis MT, et al. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 1992, 79, 111-116.
7. De Muylder X, Neven P, Sesomer M, van Belle Y, Vanderick G, De Muylder E. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 1991, 36, 127-130.
8. Rutqvist LE, Johansson H, Signomklao T, et al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995, 87, 645-651.
9. van Leeuwen FE, Benraadt J, Coebergh JW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994, 343, 448-452.
10. Seoud MA, Johnson J, Weed Jr. JC. Gynecologic tumours in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993, 82, 165-169.